Medical Research and Clinical Trials

Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists

• Medical Research and Clinical Trials

Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists

Suro Senen June 26, 2026

URBANA-CHAMPAIGN, IL – In a landmark study poised to redefine the future of medical diagnostics, new research...

Read More Read more about Revolutionizing Breast Cancer Screening: AI as a Collaborative Partner, Not a Replacement for Radiologists

Otsuka’s Centanafadine Poised for ADHD Market Entry as FDA Review Nears Completion

• Medical Research and Clinical Trials

Otsuka’s Centanafadine Poised for ADHD Market Entry as FDA Review Nears Completion

Reynand Wu June 26, 2026

Otsuka Pharmaceutical’s innovative ADHD treatment, centanafadine, is on the cusp of potential US market approval, with the...

Read More Read more about Otsuka’s Centanafadine Poised for ADHD Market Entry as FDA Review Nears Completion

Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

• Medical Research and Clinical Trials

Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

Suro Senen June 26, 2026

Cambridge, UK – In a landmark study published in The Lancet Oncology, researchers from the University of...

Read More Read more about Removing ovaries and fallopian tubes linked to lower risk of early death among breast cancer patients with BRCA cancer genes

Breakthrough at Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

• Medical Research and Clinical Trials

Breakthrough at Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

Raul Delapena Setiawan June 25, 2026

LA JOLLA, CA – May 12, 2025 – A groundbreaking study from the Salk Institute has illuminated...

Read More Read more about Breakthrough at Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

A Breakthrough in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers

• Medical Research and Clinical Trials

A Breakthrough in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers

Nana Muazin June 25, 2026

Cambridge, UK – In a monumental stride forward for cancer treatment, researchers at Cambridge have announced a...

Read More Read more about A Breakthrough in Breast Cancer Treatment: Cambridge Researchers Achieve 100% Survival in Aggressive Inherited Cancers

Viking Therapeutics Advances Promising Weight Loss Candidate VK3019 into Human Trials

• Medical Research and Clinical Trials

Viking Therapeutics Advances Promising Weight Loss Candidate VK3019 into Human Trials

Azzam Bilal Chamdy June 25, 2026

San Diego, CA – June 25, 2025 – Viking Therapeutics, a clinical-stage biopharmaceutical company, has officially launched...

Read More Read more about Viking Therapeutics Advances Promising Weight Loss Candidate VK3019 into Human Trials

Revolutionary Breakthrough: Ultra-Rapid Genetic Diagnosis Poised to Transform Brain Tumour Care

• Medical Research and Clinical Trials

Revolutionary Breakthrough: Ultra-Rapid Genetic Diagnosis Poised to Transform Brain Tumour Care

Sagoh June 25, 2026

Nottingham, UK – In a monumental leap forward for oncology, scientists and clinicians in Nottingham have unveiled...

Read More Read more about Revolutionary Breakthrough: Ultra-Rapid Genetic Diagnosis Poised to Transform Brain Tumour Care

Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup

• Medical Research and Clinical Trials

Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup

Asep Darmawan June 25, 2026

New York, NY – [Date of Publication] – Pfizer has announced topline results from its pivotal Phase...

Read More Read more about Pfizer’s Sigvotatug Vedotin Fails to Meet Primary Endpoint in Previously Treated NSCLC Trial, But Shows Promise in Subgroup

New Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Challenging Conventional Wisdom

• Medical Research and Clinical Trials

New Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Challenging Conventional Wisdom

Dwi Wanna June 25, 2026

Memphis, TN – October 26, 2023 – In a groundbreaking revelation poised to significantly reshape the landscape...

Read More Read more about New Study Reveals Genetic Predisposition as Major Driver of Secondary Cancers in Childhood Survivors, Challenging Conventional Wisdom

Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

• Medical Research and Clinical Trials

Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery

Rifan Muazin June 25, 2026

Cambridge, MA – [Insert Date] – Ascletis Pharma Inc. has announced a significant advancement in its pursuit...

Read More Read more about Ascletis Pharma Secures FDA Clearance for Promising Obesity Drug ASC35, Pioneering Once-Monthly Subcutaneous Delivery